Medical research

Clinical trials: Two arms are better than one

The German Institute for Quality and Efficiency in Health Care (IQWiG) has responded critically to a reflection paper by the European Medicines Agency (EMA) on the approval of new drugs based on single-arm studies.

Diseases, Conditions, Syndromes

Creating an iPS cell resource for rare and intractable diseases

A team of researchers led by Professor Megumu K. Saito have undertaken a massive effort to build an induced pluripotent stem (iPS) cell resource for rare diseases, enabling research and development of novel diagnostic tools ...

page 5 from 40